Your browser is no longer supported. Please, upgrade your browser.
Settings
CRME Cardiome Pharma Corp. daily Stock Chart
CRME [NASD]
Cardiome Pharma Corp.
Index- P/E- EPS (ttm)-0.98 Insider Own0.80% Shs Outstand32.03M Perf Week0.00%
Market Cap96.09M Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float31.27M Perf Month3.09%
Income-21.40M PEG- EPS next Q-0.16 Inst Own76.60% Short Float0.45% Perf Quarter9.49%
Sales23.00M P/S4.18 EPS this Y-19.70% Inst Trans-0.23% Short Ratio2.49 Perf Half Y-1.64%
Book/sh1.41 P/B2.13 EPS next Y49.30% ROA-38.60% Target Price6.77 Perf Year-44.44%
Cash/sh0.98 P/C3.05 EPS next 5Y28.00% ROE-93.00% 52W Range2.35 - 6.36 Perf YTD8.70%
Dividend- P/FCF- EPS past 5Y-19.80% ROI-74.80% 52W High-52.83% Beta1.11
Dividend %- Quick Ratio4.20 Sales past 5Y-20.60% Gross Margin68.30% 52W Low27.66% ATR0.10
Employees85 Current Ratio4.60 Sales Q/Q4.00% Oper. Margin-79.30% RSI (14)58.19 Volatility2.81% 3.00%
OptionableYes Debt/Eq0.48 EPS Q/Q39.80% Profit Margin-93.40% Rel Volume0.41 Prev Close2.99
ShortableYes LT Debt/Eq0.48 EarningsMar 09 AMC Payout- Avg Volume56.58K Price3.00
Recom1.90 SMA203.00% SMA505.43% SMA200-14.35% Volume23,107 Change0.33%
Dec-22-16Initiated Leerink Partners Outperform
Jun-01-16Initiated H.C. Wainwright Buy $9.50
Jan-08-15Initiated Brean Capital Buy $13
Jan-07-14Initiated R. F. Lafferty Buy $9
Mar-20-12Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $1.50
Apr-27-11Upgrade RBC Capital Mkts Sector Perform → Outperform $8
Dec-08-10Initiated Wedbush Outperform $8.50
Oct-22-10Reiterated RBC Capital Mkts Sector Perform $10 → $9
Jun-23-10Reiterated UBS Buy $8.80 → $10.75
Aug-12-09Reiterated RBC Capital Mkts Sector Perform $11.50 → $9
Mar-19-09Reiterated Leerink Swann Outperform $8 → $6
Dec-01-08Reiterated Oppenheimer Outperform $18 → $15
Nov-17-08Reiterated Leerink Swann Outperform $15 → $8
Aug-12-08Reiterated RBC Capital Mkts Sector Perform $13.50 → $11.50
Aug-12-08Reiterated Lehman Brothers Equal-Weight $10 → $8
Jul-16-08Downgrade RBC Capital Mkts Outperform → Sector Perform $13.50
Mar-20-08Initiated Wachovia Outperform
Mar-11-08Initiated BMO Capital Markets Market Perform
Oct-09-07Initiated Lehman Brothers Equal-weight
Feb-23-07Initiated Bear Stearns Outperform $17
Dec-22-16 06:58AM  Coverage initiated on Cardiome Pharma by Leerink Partners
Dec-20-16 08:00AM  Cardiome Announces Commercial Launch of XYDALBA (dalbavancin) in Germany PR Newswire
08:00AM  Cardiome Announces Commercial Launch of XYDALBA (dalbavancin) in Germany CNW Group
Dec-13-16 07:04PM  Is CARDIOME PHARMA CORP (CRME) a Good Stock to Buy? at Insider Monkey
Dec-08-16 11:55AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in the UK PR Newswire
11:55AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in the UK CNW Group
Nov-29-16 08:00AM  Cardiome Advances Toward the UK XYDALBA (dalbavancin) Launch PR Newswire
08:00AM  Cardiome Advances Toward the UK XYDALBA (dalbavancin) Launch CNW Group
Nov-09-16 11:48AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016
Nov-07-16 08:12AM  Cardiome reports 3Q loss +9.80%
08:00AM  Cardiome Reports Third Quarter 2016 Financial Results PR Newswire
08:00AM  Cardiome Reports Third Quarter 2016 Financial Results CNW Group
Nov-01-16 08:00AM  Cardiome to Reschedule Release of Third Quarter 2016 Financial Results PR Newswire
08:00AM  Cardiome to Reschedule Release of Third Quarter 2016 Financial Results CNW Group
Oct-28-16 08:00AM  Cardiome to Hold Third Quarter 2016 Financial Results Conference Call on November 7 PR Newswire
08:00AM  Cardiome to Hold Third Quarter 2016 Financial Results Conference Call on November 7 CNW Group
Oct-26-16 09:14AM  New Strong Sell Stocks for October 26th
Oct-14-16 09:15AM  New Strong Sell Stocks for October 14th
08:00AM  Cardiome Announces Initiation of Commercial Operations in Canada, Eh PR Newswire
08:00AM  Cardiome Announces Initiation of Commercial Operations in Canada, Eh CNW Group
Aug-16-16 08:00AM  Cardiome Announces Recent Insider Purchases PR Newswire
08:00AM  Cardiome Announces Recent Insider Purchases CNW Group
Aug-11-16 10:44AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 04:47PM  Cardiome reports 2Q loss
04:00PM  Cardiome Reports Second Quarter 2016 Financial Results PR Newswire
04:00PM  Cardiome Reports Second Quarter 2016 Financial Results CNW Group
04:00PM  Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency PR Newswire
04:00PM  Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency CNW Group
Aug-08-16 08:00AM  Cardiome Announces the Addition of Two Key Members to its Management Team PR Newswire
08:00AM  Cardiome Announces the Addition of Two Key Members to its Management Team CNW Group
Aug-03-16 04:30PM  Cardiome to Hold Second Quarter 2016 Financial Results Conference Call on August 9 PR Newswire
04:30PM  Cardiome to Hold Second Quarter 2016 Financial Results Conference Call on August 9 CNW Group
Jul-29-16 09:53AM  Cardiome Closes Public Offering of 11,500,000 Common Shares PR Newswire
09:53AM  Cardiome Closes Public Offering of 11,500,000 Common Shares CNW Group
Jul-27-16 04:04PM  New York Community Bank Drops in on Wednesdays 52-Week Low Club at 24/7 Wall St.
Jul-26-16 04:08PM  Noodles, Cardiome Lead Tuesdays 52-Week Low Club at 24/7 Wall St. -43.21%
08:38AM  Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares PR Newswire
08:38AM  Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares CNW Group
Jul-25-16 04:01PM  Cardiome Announces Proposed Public Offering of Common Shares PR Newswire
04:01PM  Cardiome Announces Proposed Public Offering of Common Shares CNW Group
Jul-18-16 08:00AM  Ionis Pharmaceuticals (IONS) in Focus: Stock Soars 11.3%
Jul-14-16 08:00AM  ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimbursement in Italy PR Newswire
08:00AM  ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimbursement in Italy CNW Group
Jun-24-16 08:00AM  Cardiome Pharma Corp. Announces Voting Results PR Newswire
08:00AM  Cardiome Pharma Corp. Announces Voting Results CNW Group
Jun-14-16 08:00AM  Cardiome Announces Term Loan Agreement with CRG-Managed Funds PR Newswire
08:00AM  Cardiome Announces Term Loan Agreement with CRG-Managed Funds CNW Group
Jun-04-16 11:25AM  2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially at 24/7 Wall St.
May-23-16 01:23PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
08:25AM  Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
May-13-16 07:11AM  Cardiome reports 1Q loss
07:00AM  Cardiome Reports First Quarter 2016 Financial Results PR Newswire
07:00AM  Cardiome Reports First Quarter 2016 Financial Results CNW Group
May-12-16 08:00AM  Cardiome Announces the Launch of ESMOCARD Solution for Injection in France PR Newswire
08:00AM  Cardiome Announces the Launch of ESMOCARD Solution for Injection in France CNW Group
May-11-16 08:00AM  Cardiome to Hold First Quarter 2016 Financial Results Conference Call on May 13 PR Newswire
08:00AM  Cardiome to Hold First Quarter 2016 Financial Results Conference Call on May 13 CNW Group
08:00AM  Cardiome Announces Publication of Spanish Emergency Department BRINAVESS Study PR Newswire
08:00AM  Cardiome Announces Publication of Spanish Emergency Department BRINAVESS Study CNW Group
May-10-16 09:45AM  Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More Zacks
May-05-16 04:15PM  Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets PR Newswire
04:15PM  Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets CNW Group
Apr-28-16 08:00AM  Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference PR Newswire
08:00AM  Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference CNW Group
Apr-25-16 09:16AM  New Strong Sell Stocks for April 25th Zacks -5.23%
Apr-21-16 06:30PM  A Closer Look Into Veritas Pharma Gurufocus
Apr-14-16 08:51AM  New Strong Sell Stocks for April 14th
Apr-07-16 01:04PM  CARDIOME PHARMA CORP Financials
Mar-31-16 08:00AM  Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation PR Newswire
08:00AM  Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation CNW Group
Mar-29-16 09:07AM  New Strong Sell Stocks for March 29th +6.87%
Mar-24-16 08:47AM  New Strong Sell Stocks for March 24th
Mar-23-16 02:54PM  Fairholme Cuts Stake in Sears Holdings Corp (SHLD), Ubben Sells Even More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Moves at Insider Monkey
Mar-21-16 01:25PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2015 By the Numbers
10:05AM  New Strong Sell Stocks for March 21st
Mar-10-16 07:27AM  Cardiome reports 4Q loss
07:00AM  Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results PR Newswire
07:00AM  Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results CNW Group
Mar-07-16 05:53PM  Cardiome Announces Filing of Prospectus Supplements PR Newswire
05:53PM  Cardiome Announces Filing of Prospectus Supplements CNW Group
Mar-04-16 03:24PM  Cardiome To Hold Fourth Quarter And Full Year 2015 Financial Results Conference Call On March 10 PR Newswire +6.16%
03:24PM  Cardiome To Hold Fourth Quarter And Full Year 2015 Financial Results Conference Call On March 10 CNW Group
Feb-19-16 04:46PM  Cardiome announces filing of shelf prospectus and registration statement PR Newswire
04:46PM  Cardiome announces filing of shelf prospectus and registration statement CNW Group
Feb-10-16 08:00AM  Cardiome To Present At The 5th Annual Leerink Partners Global Healthcare Conference PR Newswire
08:00AM  Cardiome To Present At The 5th Annual Leerink Partners Global Healthcare Conference CNW Group
Jan-27-16 12:30PM  Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA at noodls -7.18%
08:00AM  Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA PR Newswire
08:00AM  Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA CNW Group
Jan-21-16 08:00AM  Cardiome Announces the Launch of ESMOCARD LYO in Belgium PR Newswire +8.25%
08:00AM  Cardiome Announces the Launch of ESMOCARD LYO in Belgium CNW Group
Jan-13-16 08:00AM  Cardiome announces filing of marketing authorization application for intravenous vernakalant in the Kingdom Of Saudi Arabia PR Newswire -12.99%
08:00AM  Cardiome announces filing of marketing authorization application for intravenous vernakalant in the Kingdom Of Saudi Arabia CNW Group
Jan-12-16 09:18AM  Cardiome Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC PR Newswire
09:18AM  Cardiome Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC CNW Group
Jan-07-16 04:50PM  Cardiome/SteadyMed's PAH Drug Approved for Review in EU -7.23%
Jan-06-16 08:00AM  Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency PR Newswire
08:00AM  Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency GlobeNewswire
08:00AM  Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency CNW Group
Jan-05-16 08:00AM  Cardiome Enters Commercialization Agreement with Chong Kun Dang for BRINAVESS® in South Korea PR Newswire
Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of cardiovascular therapies that enhance the life and health of patients suffering from heart diseases. It offers BRINAVESS (vernakalant IV) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; and develops TREVYENT for use in treating pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is based in Vancouver, Canada.